Fresenius SE & Co. (OTCMKTS:FSNUY) Stock Price Down 5.2% – Here’s Why

Posted by Andrew Walz on May 22nd, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report)’s stock price was down 5.2% during trading on Friday . The company traded as low as $11.22 and last traded at $11.22. Approximately 49,496 shares changed hands during trading, a decline of 52% from the average daily volume of 104,004 shares. The stock had previously closed at $11.84.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on FSNUY shares. Citigroup reaffirmed a “buy” rating on shares of Fresenius SE & Co. in a report on Tuesday, February 3rd. Morgan Stanley reissued an “overweight” rating on shares of Fresenius SE & Co. in a report on Monday, April 20th. Three analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has an average rating of “Buy”.

Check Out Our Latest Stock Report on Fresenius SE & Co.

Fresenius SE & Co. Stock Down 3.8%

The stock has a market capitalization of $25.65 billion, a P/E ratio of 15.18 and a beta of 0.68. The firm’s fifty day moving average is $12.52 and its 200-day moving average is $13.77. The company has a current ratio of 1.32, a quick ratio of 1.00 and a debt-to-equity ratio of 0.47.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.01). Fresenius SE & Co. had a net margin of 6.55% and a return on equity of 10.29%. The firm had revenue of $6.75 billion for the quarter, compared to the consensus estimate of $6.79 billion. As a group, equities research analysts predict that Fresenius SE & Co. will post 1.05 earnings per share for the current year.

Fresenius SE & Co. Company Profile

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.